1 Ocak 2020 Dergi makalesi Açık Erişim

Ozgen, Ufuk; Sener, Sila Ozlem; Smejkal, Karel; Vaclavik, Jiri; Senol Deniz, Fatma Sezer; Erdogan Orhan, Ilkay; Svajdlenka, Emil; Goren, Ahmet C.; Zemlicka, Milan

Dublin Core

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Ozgen, Ufuk</dc:creator>
  <dc:creator>Sener, Sila Ozlem</dc:creator>
  <dc:creator>Smejkal, Karel</dc:creator>
  <dc:creator>Vaclavik, Jiri</dc:creator>
  <dc:creator>Senol Deniz, Fatma Sezer</dc:creator>
  <dc:creator>Erdogan Orhan, Ilkay</dc:creator>
  <dc:creator>Svajdlenka, Emil</dc:creator>
  <dc:creator>Goren, Ahmet C.</dc:creator>
  <dc:creator>Zemlicka, Milan</dc:creator>
  <dc:date>2020-01-01</dc:date>
  <dc:description>Objectives: The scope of the present study was to specify the therapeutic potential for neurodegenerative diseases through evaluating cholinesterase and tyrosinase (TYR) inhibitory and antioxidant activity of Lysimachia verticillaris (LV), and to isolate the major compounds considering the most active fraction.</dc:description>
  <dc:identifier>https://aperta.ulakbim.gov.trrecord/5459</dc:identifier>
  <dc:identifier>oai:zenodo.org:5459</dc:identifier>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>http://www.opendefinition.org/licenses/cc-by</dc:rights>
  <dc:source>TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES 17(5) 528-534</dc:source>
  <dc:title>Cholinesterase and Tyrosinase Inhibitory Potential and Antioxidant Capacity of Lysimachia verticillaris L. and Isolation of the Major Compounds</dc:title>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:type>publication-article</dc:type>
</oai_dc:dc>